ALKT CEO granted 423,217 restricted stock units

Shootman Alex reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Shootman Alex reported acquisition or exercise transactions in this Form 4 filing.

ALKAMI TECHNOLOGY, INC. Chief Executive Officer Alex Shootman reported two equity awards of common stock in the form of restricted stock units (RSUs). One grant covers 211,609 RSUs that vest in 16 quarterly installments starting on March 1, 2026, with each RSU convertable into one share of common stock upon vesting. A second grant covers 211,608 RSUs that vest in four equal annual installments beginning on March 1, 2027, and the underlying shares are subject to transfer restrictions for one year after each vesting date. Following these awards, his reported direct holdings in common stock increased, reflecting additional equity-based compensation rather than open-market purchases.

Insider Trade Summary

Grant/Award: 423,217 shares

Grant/Award 2 txns

Insider Shootman Alex

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	211,609	$0.00	$0.00
Grant/Award	Common Stock	211,608	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,221,850 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") which vest in 16 quarterly installments with a vesting commencement date of March 1, 2026. Each RSU represents a contingent right to receive one share of common stock.
2. F2. Represents an award of RSUs that will vest in four equal annual installments beginning on March 1, 2027. Upon settlement, the shares of Common Stock underlying the RSUs are subject to transfer restrictions for one year following the vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ALKT CEO Alex Shootman report on this Form 4?

Alex Shootman reported receiving two grants of restricted stock units. One award is for 211,609 RSUs and another for 211,608 RSUs, both tied to ALKAMI TECHNOLOGY, INC. common stock and structured as equity-based compensation rather than cash or open-market share purchases.

How many ALKT restricted stock units were granted to the CEO in total?

The CEO received a total of 423,217 restricted stock units tied to ALKT common stock. This consists of one grant of 211,609 RSUs and a second grant of 211,608 RSUs, both recorded as acquisitions at a price of $0.00 per share on the same grant date.

What are the vesting terms for the 211,609 ALKT RSU grant to the CEO?

The 211,609 RSU grant vests in 16 quarterly installments beginning March 1, 2026. Each restricted stock unit represents a contingent right to receive one share of ALKAMI TECHNOLOGY, INC. common stock as the vesting schedule is satisfied over the multi-year period.

How do the 211,608 ALKT RSUs granted to the CEO vest and settle?

The 211,608 RSUs vest in four equal annual installments starting March 1, 2027. When each installment vests, the underlying ALKAMI TECHNOLOGY, INC. common shares are delivered, but those shares are subject to transfer restrictions for one year following each respective vesting date.

Did the ALKT CEO buy or sell shares on the open market in this Form 4?

The Form 4 shows equity awards, not open-market trades. Both transactions are coded as grants or awards (code A) of restricted stock units at a stated price of $0.00 per share, reflecting compensation rather than discretionary stock purchases or sales.

What is Alex Shootman’s reported ALKT share ownership after these RSU awards?

After the first RSU grant, total reported direct holdings were 1,010,242 common shares. After the second RSU grant, total reported direct holdings rose to 1,221,850 common shares, reflecting the additional restricted stock unit awards disclosed in this Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 07:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shootman Alex

(Last) (First) (Middle)

C/O ALKAMI TECHNOLOGY, INC.

5601 GRANITE PARKWAY, SUITE 120

(Street)

PLANO TX 75024

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALKAMI TECHNOLOGY, INC. [ ALKT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		211,609(1)	A	$0	1,010,242	D
Common Stock	03/04/2026		A		211,608(2)	A	$0	1,221,850	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") which vest in 16 quarterly installments with a vesting commencement date of March 1, 2026. Each RSU represents a contingent right to receive one share of common stock.

2. Represents an award of RSUs that will vest in four equal annual installments beginning on March 1, 2027. Upon settlement, the shares of Common Stock underlying the RSUs are subject to transfer restrictions for one year following the vesting date.

Remarks:

	/s/ Douglas A. Linebarger, as Attorney-in-Fact for Alex Shootman	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.